Fig. 3. Effects of proteolytic enzyme inhibitors on the stability of KTTKS and pal-KTTKS in dermal skin extract and skin homogenates (n=3). (A) KTTKS in dermal skin extract, (B) KTTKS in skin homogenates, (C) pal-KTTKS in dermal skin extract, and (D) pal-KTTKS in skin homogenates.
© Biomolecules & Therapeutics
